SingHealth partners with OutcomesAI to integrate AI into medical workflows

NHCS and NCCS will implement the AI model for cardiology and oncology.

SingHealth has partnered with health tech startup OutcomesAI to integrate artificial intelligence into its medical institutions.

As part of OutcomesAI's Collaboratory programme, SingHealth institutions will adopt Glia®, a multi-model Artificial Medical Intelligence (AMI) that can help care teams with administrative tasks and provide patient care insights.

The National Heart Center Singapore and the National Cancer Centre Singapore are among the first to integrate Glia® into their clinical workflows, particularly for cardiology and oncology, respectively.

Meanwhile, OutcomesAI said it will work with its Collaboratory partners like SingHealth to implement and validate AI companions in speciality care workflows across in-hospital, outpatient, and virtual/at-home care settings

Follow the link for more news on

SingHealth

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia